Ascendobifemoral Bypass for the Treatment of a Thoracic Endograft Infection.

Autor: Pleger SP; Department of Vascular and Endovascular Surgery, Jung-Stilling Hospital, Siegen, Germany., Nink N; Department of Vascular and Endovascular Surgery, Jung-Stilling Hospital, Siegen, Germany., Böning A; Department of Adult and Pediatric Cardiovascular Surgery and Vascular Surgery, University Hospital of Giessen, Justus Liebig University, Giessen, Germany., Koshty A; Department of Vascular and Endovascular Surgery, Jung-Stilling Hospital, Siegen, Germany.
Jazyk: angličtina
Zdroj: The Thoracic and cardiovascular surgeon reports [Thorac Cardiovasc Surg Rep] 2017 Jan; Vol. 6 (1), pp. e32-e34. Date of Electronic Publication: 2017 Oct 09.
DOI: 10.1055/s-0037-1607272
Abstrakt: Background  Endograft infections (EIs) are rare complications after endovascular procedures in the thoracic and abdominal aortas. The challenging treatment encloses antibiotic and surgical therapies. Case Description  A 74-year-old male patient developed an EI after an endovascular procedure (thoracic endovascular aortic repair [TEVAR]). Despite a long-term oral antibiotic therapy, the clinical symptoms showed no falling trend. Because of the expanded infection from above the celiac trunk up to the aortic arch, we decided to remove the infected endograft and to implant an extra-anatomic ascendobifemoral bypass. Conclusion  The implantation of an ascendobifemoral bypass was a successful treatment option for EIs after TEVAR.
Databáze: MEDLINE